Table 4. Clinical studies of BH3 mimetic as anticancer drugs.
Agents | Nature of the agent | Disease type | Phase | Reference |
---|---|---|---|---|
Obatoclax | BH3 mimetic | SCLC and myelofibrosis | I | 139, 140 |
Gossypol | BH3 mimetic | Metastic breast cancer and CRPC | I and II | 141, 142, 143 |
ABT-263 | BH3 mimetic | Advanced haematological cancers | I | 144 |
ABT-199 | BH3 mimetic | CLL | I | 145 |
Abbreviations: SCLC, small-cell lung cancer; CRPC, castration-resistant prostate cancer; CLL, chronic lymphocytic leukaemia